Amalgamated Bank reduced its stake in Colgate-Palmolive (NYSE:CL – Get Rating) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 221,792 shares of the company’s stock after selling 6,847 shares during the quarter. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $17,475,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Dimensional Fund Advisors LP boosted its stake in shares of Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock valued at $185,376,000 after buying an additional 94,837 shares in the last quarter. Covestor Ltd boosted its stake in shares of Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after buying an additional 1,025 shares in the last quarter. Mackenzie Financial Corp raised its holdings in Colgate-Palmolive by 8.5% during the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after purchasing an additional 146,936 shares during the last quarter. First Western Trust Bank acquired a new position in Colgate-Palmolive during the first quarter worth $569,000. Finally, Wsfs Capital Management LLC acquired a new position in Colgate-Palmolive during the first quarter worth $288,000. 77.63% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Colgate-Palmolive news, insider Jennifer Daniels sold 24,703 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $79.70, for a total transaction of $1,968,829.10. Following the transaction, the insider now owns 52,769 shares of the company’s stock, valued at approximately $4,205,689.30. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, insider Jennifer Daniels sold 24,703 shares of the firm’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $79.70, for a total value of $1,968,829.10. Following the sale, the insider now owns 52,769 shares of the company’s stock, valued at approximately $4,205,689.30. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen I. Sadove sold 12,032 shares of Colgate-Palmolive stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $81.37, for a total value of $979,043.84. Following the sale, the director now directly owns 11,866 shares in the company, valued at approximately $965,536.42. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 187,748 shares of company stock worth $15,138,660. 0.34% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Colgate-Palmolive Stock Up 0.2 %
Shares of NYSE CL traded up $0.16 on Friday, hitting $76.41. The company had a trading volume of 2,151,221 shares, compared to its average volume of 4,746,906. Colgate-Palmolive has a 12-month low of $67.84 and a 12-month high of $83.81. The business has a 50 day moving average of $77.10 and a two-hundred day moving average of $76.22. The company has a quick ratio of 0.76, a current ratio of 1.23 and a debt-to-equity ratio of 20.87. The firm has a market capitalization of $63.39 billion, a P/E ratio of 39.71, a PEG ratio of 3.92 and a beta of 0.49.
Colgate-Palmolive (NYSE:CL – Get Rating) last issued its earnings results on Friday, April 28th. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.03. Colgate-Palmolive had a return on equity of 348.63% and a net margin of 8.71%. The company had revenue of $4.77 billion during the quarter, compared to the consensus estimate of $4.58 billion. During the same quarter in the prior year, the business earned $0.74 earnings per share. The company’s revenue was up 8.4% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.14 earnings per share for the current fiscal year.
Colgate-Palmolive Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, May 15th. Investors of record on Friday, April 21st were paid a $0.48 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. The ex-dividend date of this dividend was Thursday, April 20th. This represents a $1.92 annualized dividend and a dividend yield of 2.51%. Colgate-Palmolive’s payout ratio is 100.00%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.